J.P. Morgan Maintains XP Inc(XP.US) With Buy Rating, Cuts Target Price to $29
XP Analyst Ratings
JP Morgan Maintains Overweight on XP, Raises Price Target to $29
Citi Maintains XP Inc(XP.US) With Buy Rating
Morgan Stanley Maintains XP Inc(XP.US) With Hold Rating, Maintains Target Price $24
XP Inc: Hold Rating Maintained Amid Stable Valuation and Modest Earnings Adjustment
BofA Securities Maintains XP Inc(XP.US) With Buy Rating, Maintains Target Price $25
Morgan Stanley Maintains XP Inc(XP.US) With Hold Rating, Maintains Target Price $24
BofA Securities Maintains XP Inc(XP.US) With Buy Rating, Maintains Target Price $25
Citi Maintains XP Inc(XP.US) With Buy Rating, Maintains Target Price $27
Strong Performance and Promising Outlook Justify Buy Rating for XP Inc.
XP Analyst Ratings
Goldman Sachs Maintains Neutral on XP, Lowers Price Target to $19
XP Analyst Ratings
UBS Downgrades XP to Neutral From Buy, Cuts Price Target to $21 From $30
Bradesco BBI Downgrades XP to Neutral From Outperform, Cuts Price Target to $19 From $31
XP Analyst Ratings
B of A Securities Maintains Buy on XP, Lowers Price Target to $25
XP Analyst Ratings
Citigroup Maintains Buy on XP, Lowers Price Target to $27